Deltex Medical shares soar as TrueVue testing progresses "to plan"

(Alliance News) - Deltex Medical Group PLC on Monday said testing of its new monitor has so far ...

Alliance News 4 December, 2023 | 11:12AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - Deltex Medical Group PLC on Monday said testing of its new monitor has so far delivered positive results, and that it plans to reduce the size of its board to help cut costs.

The stock was up 18% at 0.18 pence in London on Monday morning.

The Chichester, England-based company, which manufactures blood circulation monitoring systems, said that in-hospital testing of its new TrueVue monitor "has been on-going for the past three months and has gone to plan, generating positive feedback on the new monitor whilst confirming that the performance is equivalent or better than for the existing device."

Deltex said it completed the first in-market sale of the new TrueVue monitor at the end of November. It has also received other initial orders for the devices, and expects to fulfil these "over the coming months". Consequently, Deltex anticipates "a strong start to the new year".

Deltex also said that follow a review of its board's composition, it has decided to reduce the number of directors on said board as part of its "ongoing efforts to realise cost savings near possible".

As a result, Deltex announced that Non-Executive Directors Julian Cazalet, Mark Wippell and Tim Irish have stepped down effective from Friday last week. However it also hired Ben Carswell, who worked as a commercial & operations director at Fiserv Inc from 2014 to 2018, as a non-executive director.

By Emma Curzon, Alliance News reporter

Comments and questions to

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Deltex Medical Group PLC 0.12 GBX 3.83 -
Fiserv Inc 149.99 USD -0.24

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures